The future of PPE
A safer, smarter solution to the threats posed by deadly infectious viruses
The challenge we face globally
Current PPE is not keeping us safe enough
SARS-CoV-2 is transmitted through large respiratory droplets generated by coughing, sneezing or even speaking, which can also survive on surfaces.
PPE plays a crucial role in interrupting the transmission of SARS-CoV-2, but research has found that a high level of viral load and the process of putting PPE on and taking it off presents a substantially increased risk of transmission.
The disposal of contaminated PPE also presents a further transmission risk, as does concern regarding the disposal of single-use PPE from a waste management perspective.
Lack of appropriate PPE
- Contact with used PPE increases the risk of transmission via fomites
- Rules around single-use PPE disposal are resulting in enormous quantities of used PPE going into landfill and our oceans
- Without access to adequate PPE, healthcare workers are more likely to become ill
- Ill healthcare workers create a supply shortage during high demand, and can contribute to further viral transmission
- Remaining available health workers are stretched beyond capacity and quality of care often reduces
- PPE shortage becomes a system-wide public health problem, rather than solely a worker’s rights or occupational health issue
- PPE for health workers is a key component of infection prevention and control; ensuring that healthcare workers are protected means more chance of preventing infection and therefore less chance of community transmission
As of May 2020, 87% of nurses in the US reported having to reuse disposable single-use N95 and respirator masks. 27% reported that they had been exposed to patients with confirmed COVID-19, without wearing appropriate PPE.
As of August 15th, 2020, 300,000 healthcare workers had been infected with COVID-19. In addition to the high number of infections, over 2,500 healthcare workers died from the virus as of that time.
In March 2020, one-third of hospitals had almost no face masks and 13% reported to have run out of plastic face shields.
ViraCoat's COVID-Eliminating PPE will:
Neutralise the threat upon contact
Vaccines alone are not completely effective against becoming seriously ill from COVID-19, and most do not effectively reduce transmissibility. Current vaccines are also likely to become less effective as the virus continues to mutate into new variants.
Having a COVID-killing coating that starts working immediately upon contact with the virus acts as an invisible ‘circuit-breaker’ in the transmission of COVID-19 via fomites and airborne droplets.
Health authorities (including the WHO) recommend that a multifaceted approach of prevention and protection is the only route to controlling COVID-19 in a sustainable manner long-term.
ViraCoat has developed a patented Virucidal, Antiviral & Antimicrobial Coating which has been scientifically demonstrated to have profound antiviral properties against SARS-CoV-2 (including new variants), Influenza (PR8 strain), and Bacteria (E. coli).
ViraCoat’s patented Coating has been incorporated into the ViraCoat COVID-19 eliminating Antiviral FFP2 Mask at a manufacturing level, to inactivate the virus and help reduce the spread of SARS-CoV-2, other viruses and bacteria within 5 minutes of contact.*
The mask is manufactured by ViraCoat in state-of-the-art Module D PPE manufacturing facilities, using our proprietary Virucidal, Antiviral & Antimicrobial Coating and other exclusively-sourced components to the highest possible standards.
* Based on current lab testing results to date.